Strikingly, Pla2r1 KO mice responded in a similar manner to glucose challenge at the beginning (D0) and at the end of the WD (D77; Figure 2b,c), highlighting protection against WD‐induced glucose intolerance. Here, PLA2R1 is linked to Wilson disease.